iMedrix KardioScreen, a CE certified mobile/portable hospital grade digital ECG unit, is touted as the first truly mobile, connected ECG solution that can be applied universally: field screening, point of care, ambulance, Cardiac ICU and at-home monitoring. The patent-pending KardioScreen solution consists of a hospital grade mobile ECG device and mobility software suite of artificial-intelligence (AI) assisted solutions. KardioScreen can be used in both snapshot short term ECG (30s) and extended observation/monitoring modes in 6- or 12-lead configuration.
KardioScreen is being used at several hospitals in Asia in a variety of use cases. An ECG taken from KardioScreen can be analyzed by a live/remote physician and AI engines in seconds. Further, the simple, deskilled use model and ability to record ECGs quickly, has been a major factor in the adoption of this solution for population screening.
Multiple layers of algorithmic and analytics solutions are added to KardioScreen to help physicians with actionable insights. This also enables a truly mobile, digital health architecture where third party devices and applications can fit in, acting as a base for Software as a Medical Device applications. KardioScreen is offered on subscription basis in Asia. With the obtainment of CE certification, iMedrix is now looking to enter markets in Europe.
If this gets your heart yearning for more details, visit iMedrix.